Response letter to laurelli et al. letter to the editor regarding enhancing telemedicine to improve global radiotherapy access
Affiliation
Division of Cancer Sciences, University of Manchester, Manchester, UK; Christie NHS Foundation Trust, Manchester, UK.Issue Date
2024
Metadata
Show full item recordCitation
Salem A, Al-Samarat F, Farhan F. Response Letter to Laurelli et al. Letter to the Editor Regarding Enhancing Telemedicine to Improve Global Radiotherapy Access. Clinical oncology (Royal College of Radiologists (Great Britain)). 2024 Dec;36(12):817-8. PubMed PMID: 39370345. Epub 2024/10/07. eng.Journal
Clinical OncologyDOI
10.1016/j.clon.2024.09.004PubMed ID
39370345Additional Links
https://dx.doi.org/10.1016/j.clon.2024.09.004Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.clon.2024.09.004
Scopus Count
Collections
Related articles
- Letter to the Editor Regarding: Enhancing Telemedicine to Improve Global Radiotherapy Access.
- Authors: Laurelli F, Caimi E, Guerini F
- Issue date: 2024 Sep
- Letter to the Editor Concerning "Telemedicine Improves Access to Care for Spine Patients with Low Socioeconomic Status." by Ye et al.
- Authors: Wang Z, Hua Y, Cao C
- Issue date: 2024 Jun
- Letter #1 Response to letter to Editor by Dr. Sarkar et al. for' who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for' is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?' Refers to PII: S2210-7789(21)00538-9.
- Authors: Jayaram A, Buhimschi IA, Buhimschi CS
- Issue date: 2022 Mar
- Letter to the editor: Reply to Ali et al.
- Authors: Kim MS, Wilke DR
- Issue date: 2024 May